67 related articles for article (PubMed ID: 1308477)
1. Suppressive effect of prostaglandin E1, but not prostacyclin, on ouabain-induced ventricular fibrillation in guinea-pigs.
Nakanishi H; Ono T; Shirasaka M; Yoshida H
Fukushima J Med Sci; 1992 Dec; 38(2):105-10. PubMed ID: 1308477
[TBL] [Abstract][Full Text] [Related]
2. On the 7-oxo-PgI2 induced lasting protection against ouabain arrhythmias in anesthetized guinea pigs.
Szilvássy Z; Szekeres L; Udvary E; Végh A
Biomed Biochim Acta; 1988; 47(10-11):S35-8. PubMed ID: 2470357
[TBL] [Abstract][Full Text] [Related]
3. 7-oxo PGI2 dramatically increases the safety margin of digitalis.
Szilvássy Z; Szekeres L; Udvary E; Karcsu S; Végh A
Bratisl Lek Listy; 1991; 92(3-4):134-7. PubMed ID: 2029654
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of ST-93 against ouabain induced arrhythmias in guinea pigs.
Tripathi RM; Kaushal R; Veeranjaneyulu A
Indian J Physiol Pharmacol; 1987; 31(2):111-6. PubMed ID: 3666879
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
Chiba S; Malik KU
J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
[TBL] [Abstract][Full Text] [Related]
6. Significance of myocardial prostaglandin biosynthesis and the influence of mechanical loading, endogenous mediators and cardiovascular drugs.
Mentz P; Pawelski KE; Giessler C; Orlowa ZR; Geling NG; Taube C
Biomed Biochim Acta; 1984; 43(8-9):S147-50. PubMed ID: 6393961
[TBL] [Abstract][Full Text] [Related]
7. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
Allan G; Levi R
J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
[TBL] [Abstract][Full Text] [Related]
8. Effect of prostaglandin E1 on ouabain-induced cardiac toxicity in anesthetized dogs.
Nakanishi H; Narui S; Yoshida F; Taguchi S; Ito G
Fukushima J Med Sci; 1977; 24(1-2):47-54. PubMed ID: 617323
[No Abstract] [Full Text] [Related]
9. Alpha- but not beta-receptor blocking agents inhibit the antiarrhythmic effect of iloprost on ouabain-induced arrhythmia in guinea-pigs.
Mest HJ; Balewska I
Biomed Biochim Acta; 1991; 50(7):943-7. PubMed ID: 1722094
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
Trimarco B; Cuocolo A; Ricciardelli B; Patrignani P; Volpe M; de Luca N; Condorelli M
J Pharmacol Exp Ther; 1986 May; 237(2):589-99. PubMed ID: 3084760
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin and prostaglandin E2 effects on adrenergic transmission in the kidney of anesthetized dog.
Susić H; Malik KU
J Pharmacol Exp Ther; 1981 Sep; 218(3):588-92. PubMed ID: 6167710
[TBL] [Abstract][Full Text] [Related]
12. The lack of involvement of central nervous system in the antiarrhythmic effects of prostaglandins E2, F2 alpha, and I2 in cat.
Rao TS; Seth SD; Manchanda SC; Nayar U
Prostaglandins; 1987 Mar; 33(3):339-50. PubMed ID: 3554368
[TBL] [Abstract][Full Text] [Related]
13. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
Jouve R; Puddu PE; Langlet F; Guillen JC; Gautier T; Cano JP; Serradimigni A
J Pharmacol; 1985; 16(2):139-57. PubMed ID: 3903352
[TBL] [Abstract][Full Text] [Related]
14. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
Panzenbeck MJ; Hintze TH; Kaley G
J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
[TBL] [Abstract][Full Text] [Related]
15. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
17. A comparison of some pharmacological actions of prostaglandin E1, 6-oxo-PGE1 and PGI2.
Adaikan PG; Tai NY; Lau LC; Karim SM; Kottegoda SR
Prostaglandins; 1984 Apr; 27(4):505-16. PubMed ID: 6203140
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
Gibson JK; Patterson E; Lucchesi BR
J Pharmacol Exp Ther; 1986 Apr; 237(1):318-25. PubMed ID: 3754279
[TBL] [Abstract][Full Text] [Related]
19. On the nature and molecular basis of prostacyclin induced late cardiac changes.
Szekeres L; Németh M; Szilvássy Z; Tósaki A; Udvary E; Végh E
Biomed Biochim Acta; 1988; 47(10-11):S6-11. PubMed ID: 3073771
[TBL] [Abstract][Full Text] [Related]
20. Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats.
Mest HJ; Rein T; Riedel A; Köpernik W; Braquet C
Agents Actions Suppl; 1992; 37():228-34. PubMed ID: 1632298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
